Cumberland Pharmaceuticals announces plans to file new drug application for ifetroban DMD program
CPIX•Cumberland Pharmaceuticals plans to submit an NDA to the FDA for ifetroban as a treatment for DMD cardiomyopathy.
CPIX•CPIX•CPIX•Cumberland Pharmaceuticals plans to submit an NDA to the FDA for ifetroban as a treatment for DMD cardiomyopathy.
Cumberland Pharmaceuticals announced plans to submit a new drug application to the FDA for ifetroban as a treatment for DMD cardiomyopathy.
